IVI, Bharat Biotech announce start of global Phase II/III clinical trial of Chikungunya vaccine
Aug 25, 2021
Hyderabad (Telangana) [India], August 25 : The International Vaccine Institute (IVI) and Bharat Biotech on Wednesday announced the beginning of Phase II/III clinical trial...